| 产品详情 |
| Edit |   |
| Product Name | Recombinant Human Spastic Paraplegia 21 |
| Description | MW: 31,585 Da. Purity >95.0% as determined by SDS-PAGE. Description: SPG21 produced in E Coli is a single, non-glycosylated polypeptide chain containing 328 amino acids (1-308 a.a.) and having a molecular mass of 94.4 kDa.SPG21 is expressed with a 20 amino acid His tag at N-Terminus and purified by proprietary chromatographic techniques.Introduction: SPG21 binds to the hydrophobic C-terminal amino acids of CD4 which take part in suppression of CD-4 dependant T cell activati |
| Size | 0.005 mg, 0.02 mg, 1 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | [SPG21 Human; Spastic Paraplegia 21 Human Recombinant; MAST; ACP33; GL010; BM-019; MASPARDIN; SPG21; Spastic paraplegia 21 autosomal recessive Mast syndrome protein; Acid cluster protein 33] |
| Gene, Accession, CAS # | SPG21, Gene ID: 51324, Accession: NP_001121361.1 |
| Catalog # | MBS143491 |
| Price | |
| Order / More Info | Recombinant Human Spastic Paraplegia 21 from MYBIOSOURCE INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|